Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
126,709,071
-
Share change
-
-6,950,969
-
Total reported value
-
$40,045,229,799
-
Put/Call ratio
-
127%
-
Price per share
-
$316.38
-
Number of holders
-
1,079
-
Value change
-
-$2,176,332,017
-
Number of buys
-
411
-
Number of sells
-
564
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q1 2020
As of 31 Mar 2020,
BIOGEN INC. - COM (BIIB) was held by
1,079 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
126,709,071 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, Clearbridge Investments, LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Bank of New York Mellon Corp.
This page lists
1,085
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.